CM4Cure SA
9.4 FTEThe score of CM4Cure shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +102 % Total assets +257 % Headcount (avg FTE) +236 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CM4Cure's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −152,297 € | ||||
| Equity | €1.77m | ||||
| Cash | 229,025 € | ||||
| EBITDA | −154,846 € | ||||
| Total assets | €4.57m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Apr 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 10 Apr 2024
- Year ended 31 Dec 2022filed on 04 Apr 2023
- Year ended 31 Dec 2021filed on 29 Mar 2022
CM4Cure's financial analysis
- Solvency38.8%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CM4Cure
CM4Cure's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.658.810
- VAT number
- BE0765658810
- Peppol
- Registered · 0208:0765658810 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Mar 2021
- Registered office
- 4000 Liège
- Size
- Micro · 9.4 FTE
- Latest accounts
- 2025 · filed on 29 Apr 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
CM4Cure (SA) has been based in Liège since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 152,297 € and equity of €1.77m; its revenue is not published. With 9.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 38.8%, below the median of its sector (58.2%).
Companies similar to CM4Cure
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Hebrimo Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €4.71m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- Envitec Measurements AND Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
- BioKuris Research and experimental development on natural sciences and engineering Herstal · balance sheet €5.85m
- K5 Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €3.56m
- ImmuneSpec Research and experimental development on natural sciences and engineering Niel · balance sheet €3.54m
- Dr. J. Bellon Research and experimental development on natural sciences and engineering Buggenhout · balance sheet €3.14m
Frequently asked questions about CM4Cure
What is the revenue of CM4Cure?
CM4Cure files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CM4Cure?
In Belgium, the VAT number is the company number prefixed with BE: BE0765658810 for CM4Cure, if the company is VAT-registered. Its company number (CBE) is 0765.658.810.
Where is the registered office of CM4Cure?
According to the CBE register, the registered office of CM4Cure is in 4000 Liège.
What is the equity of CM4Cure?
At the close of the 2025 financial year, the equity of CM4Cure amounts to 1,771,654 €, a solvency of 38.8% of total assets.
How many people work at CM4Cure?
9.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages CM4Cure?
The register lists 7 active mandates at CM4Cure. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CM4Cure
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →